Purdue Pharma’s Sackler Family Opioid Deal in Jeopardy

Purdue Pharma’s Sackler Family Opioid Deal in Jeopardy

Judging Freedom

The OxyContin maker’s chapter 11 reorganization plan hinges on legal questions that will determine owner Sackler family’s future liabilities for their role in the opioid epidemic.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Activity

Switch to the Fountain App